KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Net Income (2016 - 2025)

Charles River Laboratories International has reported Net Income over the past 16 years, most recently at -$276.3 million for Q4 2025.

  • For Q4 2025, Net Income fell 29.26% year-over-year to -$276.3 million; the TTM value through Dec 2025 reached -$142.2 million, down 662.11%, while the annual FY2025 figure was -$142.2 million, 662.11% down from the prior year.
  • Net Income for Q4 2025 was -$276.3 million at Charles River Laboratories International, down from $55.6 million in the prior quarter.
  • Over five years, Net Income peaked at $189.1 million in Q4 2022 and troughed at -$276.3 million in Q4 2025.
  • A 5-year average of $62.7 million and a median of $92.1 million in 2021 define the central range for Net Income.
  • Biggest five-year swings in Net Income: surged 48.94% in 2022 and later plummeted 213.12% in 2024.
  • Year by year, Net Income stood at $139.8 million in 2021, then skyrocketed by 35.24% to $189.1 million in 2022, then dropped by 0.08% to $189.0 million in 2023, then plummeted by 213.12% to -$213.7 million in 2024, then dropped by 29.26% to -$276.3 million in 2025.
  • Business Quant data shows Net Income for CRL at -$276.3 million in Q4 2025, $55.6 million in Q3 2025, and $52.7 million in Q2 2025.